Phastar Net-Zero Target Approved by the Science Based Targets Initiative

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

PDUFA Crucial for Biopharmaceutical Innovation in the US

The United States happens to lead the world when...

Fangzhou Inc. at PHARMCHINA Showcases AI-Powered Healthcare

The 4th Annual "Internet + Pharma" Service Innovation Conference,...

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Piramal Pharma Expands Lexington Sterile Injectables Plant

Piramal Pharma has started work on the expansion of...

Phastar, a global specialist biometrics contract research organization (CRO), has had its net-zero target approved by the Science Based Targets initiative (SBTi). The SBTi is a global body enabling businesses to set ambitious emissions reductions targets in line with the latest climate science and is considered the gold standard for net-zero.

A core component of Phastar’s commitment to SBTi is the ambitious pledge to achieve the Science Based Targets initiative (SBTi) Net-Zero Standard by 2035. By adopting stringent sustainability standards, Phastar aims to reduce its carbon footprint, engage with stakeholders, and promote responsible business practices.

Phastar Chief Executive Officer Graham Clark said: “Having our net-zero target approved by the SBTi underscores our commitment to corporate responsibility and sustainable business practices. As a company, we pride ourselves on our mission to make a meaningful difference in the world, and on being a great company to work with and work for.

“Reducing our carbon emission is part of our comprehensive Environmental, Social, and Governance (ESG) strategy, which includes tree planting initiatives in Kenya and Scotland, a Carbon Offset programme, and a move to using only green energy suppliers. We want to lead the CRO industry in its efforts to combat climate change and pursue a net-zero future – and SBTi approval shows we are on track to achieving that goal.”

Phastar has already embarked on a journey to hit net zero by 2035. Measures taken so far include strengthening the company’s emissions-measurement processes to enable more easy tracking. The organization has also developed and launched a sustainability strategy to outline exactly how it will reduce its emissions, as well as help its suppliers to do the same. Phastar also plans to roll out policies, initiatives, and incentives throughout its global team to help it become a more environmentally friendly business.

Latest stories

Related stories

PDUFA Crucial for Biopharmaceutical Innovation in the US

The United States happens to lead the world when...

Fangzhou Inc. at PHARMCHINA Showcases AI-Powered Healthcare

The 4th Annual "Internet + Pharma" Service Innovation Conference,...

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Piramal Pharma Expands Lexington Sterile Injectables Plant

Piramal Pharma has started work on the expansion of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back